An observational study in Knee Injuries, sponsored by The University of Tennessee, Knoxville. Completed at 3 sites in United States. Open to participants aged 40 Years to 85 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-10-21.
Sponsored by The University of Tennessee, Knoxville · Observational
Smith \& Nephew's first edition of the Journey posterior stabilizing total knee arthroplasty was analyzed by the Center for Musculoskeletal Research in a past research study, and it was determined that subjects experienced more normal-like kinematic patterns. They also achieved excessive axial rotation and a decrease in weight-bearing knee flexion. Since Smith \& Nephew has made modifications to the Journey bi-cruciate stabilizing (BCS) total knee arthroplasty (TKA) design, researchers will again evaluate the kinematics of subjects implanted with the revised design to determine if subjects experience normal-like kinematic patterns and if greater weight-bearing knee flexion is achieved. The objective for this study is to analyze the in vivo kinematics for subjects implanted with a 2nd generation Journey BCS TKA and compare those patterns to subjects having a normal knee and those having the 1st generation Journey posterior stabilizing (PS) TKA that were analyzed in the previous study.
249 studies on the registry are indexed under Knee Injuries; 48 are open to participants now.
This study's enrollment of 50 is below the median of 90 across 79 observational studies indexed under Knee Injuries.
Browse Knee Injuries studies →The University of Tennessee, Knoxville is the lead sponsor of 95 studies on the registry; 6 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients implanted with a Smith \& Nephew Journey II bi-cruciate stabilizing (BCS) implanted by Dr. Harold E. Cates or subjects with a healthy knee
Inclusion Criteria for implanted subjects:
Exclusion Criteria for implanted subjects:
Inclusion Criteria for non-implanted subjects:
Exclusion Criteria for non-implanted subjects:
Subjects must be implanted with a Smith \& Nephew Journey II bi-cruciate stabilizing (BCS) total knee arthroplasty (TKA) implanted by Dr. Harold Cates
Device: Journey II BCS TKA
Subjects must have a healthy, functioning knee with no osteoarthritis or knee pathologies
Kinematics Translations During Deep Knee Bend (DKB) Activity
Anterior Posterior (AP) translations of medial femoral condyles during DKB Anterior Posterior (AP) translations of lateral femoral condyles during DKB
Time frame: 3 months post-operative
Kinematics During Deep Knee Bend (DKB) Activity
Maximum weight-bearing flexion during DKB Axial Rotation (AR) during DKB
Time frame: 3 months post-operative
Kinematics Translations During Squat to Stand (S2S) Activity
Anterior Posterior (AP) translations of lateral femoral condyles during squat to stand (S2S) activity Anterior Posterior (AP) translations of medial femoral condyles during S2S
Time frame: 3 months post-operative
Kinematics During Squat to Stand (S2S) Activity
Maximum weight-bearing flexion during squat to stand (S2S) activity Axial Rotation (AR) of the femur during S2S
Time frame: 3 months post-operative
Kinematics Translations During Ramp up Activity
AP Translations of the Medial and Lateral Femoral Condyles During Ramp Up activity
Time frame: 3 months post-operative
Kinematics During Ramp up Activity
AR of the femur during Ramp Up activity
Time frame: 3 months post-operative
Kinematics Translations During Ramp Down Activity
AP Translations of the Medial and Lateral Femoral Condyles during Ramp down activity
Time frame: 3 months post-operative
Kinematics During Ramp Down Activity
AR of the femur during ramp down activity
Time frame: 3 months post-operative
| Milestone | Smith & Nephew Journey II BCS TKA | Normal Knee |
|---|---|---|
| Started | 40 | 10 |
| Completed | 40 | 10 |
| Not completed | 0 | 0 |
Anterior Posterior (AP) translations of medial femoral condyles during DKB Anterior Posterior (AP) translations of lateral femoral condyles during DKB
| mm | Smith & Nephew Journey II BCS TKA | Normal Knee |
|---|---|---|
| AP trans lateral femoral condyles 0-90 degrees | -10.11 ± 4.80 | -13.15 ± 4.78 |
| AP trans medial femoral condyles 0-90 degrees | -5.15 ± 2.51 | -4.93 ± 1.78 |
Maximum weight-bearing flexion during DKB Axial Rotation (AR) during DKB
| degrees | Smith & Nephew Journey II BCS TKA | Normal Knee |
|---|---|---|
| Max weight-bearing flexion deep knee bend | 95.6 ± 20.5 | 143.6 ± 10.5 |
| AR of the femur 0-90 degrees | 6.23 ± 4.44 | 17.88 ± 5.57 |
Anterior Posterior (AP) translations of lateral femoral condyles during squat to stand (S2S) activity Anterior Posterior (AP) translations of medial femoral condyles during S2S
| mm | Smith & Nephew Journey II BCS TKA | Normal Knee |
|---|---|---|
| AP trans of lateral femoral condyle 90-0 degrees | 11.82 ± 4.68 | 11.30 ± 4.66 |
| AP trans of medial femoral condyle 90-0 degrees | 5.49 ± 2.25 | 4.37 ± 2.12 |
Maximum weight-bearing flexion during squat to stand (S2S) activity Axial Rotation (AR) of the femur during S2S
| degrees | Smith & Nephew Journey II BCS TKA | Normal Knee |
|---|---|---|
| Kinematics During Squat to Stand (S2S) Activity | -7.78 ± 4.92 | -15.31 ± 6.21 |
AP Translations of the Medial and Lateral Femoral Condyles During Ramp Up activity
| mm | Smith & Nephew Journey II BCS TKA | Normal Knee |
|---|---|---|
| Medial Anterior Posterior Translation 0% to 33% | 0.81 ± 3.05 | -1.51 ± 1.62 |
| Medial Anterior Posterior Translation 33% to 66% | 1.21 ± 2.69 | 1.20 ± 1.15 |
| Medial Anterior Posterior Translation 66% to 100% | -3.16 ± 3.83 | 0.63 ± 1.44 |
| Lateral Anterior Posterior Translation 0-33% | 0.40 ± 1.88 | -2.72 ± 3.18 |
| Lateral Anterior Posterior Translation 33%-66% | 1.88 ± 3.50 | 3.43 ± 2.20 |
| Lateral Anterior Posterior Translation 66%-100% | -4.39 ± 5.63 | -2.24 ± 2.01 |
AR of the femur during Ramp Up activity
| degrees | Smith & Nephew Journey II BCS TKA | Normal Knee |
|---|---|---|
| AR 0% to 33% | 0.50 ± 2.97 | 2.25 ± 4.15 |
| AR 33% to 66% | -0.82 ± 2.50 | -3.64 ± 3.13 |
| AR 66% to 100% | 1.51 ± 3.67 | 3.76 ± 3.03 |
AP Translations of the Medial and Lateral Femoral Condyles during Ramp down activity
| mm | Smith & Nephew Journey II BCS TKA | Normal Knee |
|---|---|---|
| Medial Anterior Posterior Translation 0% to 33% | -0.56 ± 2.93 | -1.20 ± 1.39 |
| Medial Anterior Posterior Translation 33% to 66% | -1.34 ± 1.94 | 0.08 ± 1.21 |
| Medial Anterior Posterior Translation 66% to 100% | -0.35 ± 3.33 | 0.20 ± 2.25 |
| Lateral Anterior Posterior Translation 0-33% | -1.45 ± 4.52 | -2.59 ± 3.56 |
| Lateral Anterior Posterior Translation 33%-66% | -2.57 ± 3.15 | -1.85 ± 2.38 |
| Lateral Anterior Posterior Translation 66%-100% | -0.24 ± 4.90 | 1.36 ± 2.46 |
AR of the femur during ramp down activity
| degrees | Smith & Nephew Journey II BCS TKA | Normal Knee |
|---|---|---|
| AR 0% to 33% | 1.10 ± 3.18 | 3.30 ± 5.15 |
| AR 33% to 66% | 1.54 ± 3.39 | 3.04 ± 3.35 |
| AR 66% to 100% | -0.15 ± 3.30 | -1.81 ± 3.01 |
Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Smith & Nephew Journey II BCS TKA | — | 0/40 (0%) | 0/40 (0%) |
| Normal Knee | — | 0/10 (0%) | 0/10 (0%) |
| Age, Categorical(Participants) | Smith & Nephew Journey II BCS TKA | Normal Knee | Total |
|---|---|---|---|
| <=18 years | 0 | 0 | 0 |
| Between 18 and 65 years | 11 | 9 | 20 |
| >=65 years | 29 | 1 | 30 |
| Age, Continuous(years) | Smith & Nephew Journey II BCS TKA | Normal Knee | Total |
|---|---|---|---|
| Mean | 69.76 ± 8.30 | 57.44 ± 7.15 | 67.29 ± 9.43 |
| Sex: Female, Male(Participants) | Smith & Nephew Journey II BCS TKA | Normal Knee | Total |
|---|---|---|---|
| Female | 27 | 6 | 33 |
| Male | 13 | 4 | 17 |
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Oct 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
The University of Tennessee, Knoxville